Leu-OVA (257-264), LSIINFEKL is a variant ovalbumin epitope used to study anchor residue substitution in peptide–MHC complexes. Its sequence supports comparison with the canonical SIINFEKL motif. Researchers employ it to analyze T-cell receptor sensitivity to minor sequence changes. The peptide aids investigation of antigenic cross-recognition.
CAT No: O05003
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More